Ann Vanderplas

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 934 citations · Full text

Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network

Nancy U. Lin, Ann Vanderplas, Melissa E. Hughes et al. · Cancer · 2012 · 679 citations · Full text

Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy

Caron Melikian, TJ White, Ann Vanderplas et al. · Clinical Therapeutics · 2002 · 236 citations

Disease Management, Diabetes Management, Health Policy +9

Costs of Lower-Extremity Ulcers Among Patients With Diabetes

Karen M. Stockl, Ann Vanderplas, Eskinder Tafesse et al. · Diabetes Care · 2004 · 196 citations · Full text

Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database

Ann S. LaCasce, Jonathan L. Vandergrift, Maria Alma Rodriguez et al. · Blood · 2012 · 97 citations · Full text